Managing hepatitis C in general practice

由 Strasser, Simone I
發表在 Aust Prescr (2017)

Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?

由 Silva, Mauricio F., Strasser, Simone I., Carrilho, Flair J.
出版 2013

Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor

由 Lum, Lionel Hon Wai, Chen, Fei Wen, Jackett, Louise, Strasser, Simone I., Davis, Rebecca J.
發表在 Transplant Direct (2017)

Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients’ Experience on Rifaximin-α (PROSPER): an observational study among 550 patients

由 Krag, Aleksander, Schuchmann, Marcus, Sodatonou, Hanna, Pilot, Jeff, Whitehouse, James, Strasser, Simone I., Hudson, Mark
發表在 Hepatol Med Policy (2018)

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma

由 Vongsuvanh, Roslyn, van der Poorten, David, Iseli, Tristan, Strasser, Simone I., McCaughan, Geoffrey W., George, Jacob
發表在 PLoS One (2016)

Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance

由 Saunderson, Rebecca B., Garsia, Roger, Headley, Alexander P., McCaughan, Geoffrey W., O’Toole, Sandra, Strasser, Simone I.
出版 2013

Severe Hepatocellular Injury After Hematopoietic Cell Transplant: Incidence, Etiology, and Outcome

由 Sakai, Miwa, Strasser, Simone I., Shulman, Howard M., McDonald, Scott J., Schoch, H. Gary, McDonald, George B.
出版 2009

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

由 Adams, Leon A, Roberts, Stuart K, Strasser, Simone I, Mahady, Suzanne E, Powell, Elizabeth, Estes, Chris, Razavi, Homie, George, Jacob
發表在 J Gastroenterol Hepatol (2020)

Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma

由 Mohsen, Waled, Rodov, Marcia, Prakoso, Emilia, Charlton, Barbara, Bowen, David G, Koorey, David J, Shackel, Nicholas A, McCaughan, Geoffrey W, Strasser, Simone I
發表在 World J Gastroenterol (2017)

Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients

由 Liu, Ken, Joshi, Vikram, van Camp, Louise, Yang, Qi-Wei, Baars, Judith E, Strasser, Simone I, McCaughan, Geoffrey W, Majumdar, Avik, Saxena, Payal, Kaffes, Arthur J
發表在 World J Gastroenterol (2017)

Impact of Having a Planned Additional Operation at Time of Liver Transplant on Graft and Patient Outcomes

由 Salimi, Shirin, Pandya, Keval, Sastry, Vinay, West, Claire, Virtue, Susan, Wells, Mark, Crawford, Michael, Pulitano, Carlo, McCaughan, Geoffrey W., Majumdar, Avik, Strasser, Simone I., Liu, Ken
發表在 J Clin Med (2020)

Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study

由 Vidot, Helen, Cvejic, Erin, Finegan, Liam J., Shores, E. Arthur, Bowen, David G., Strasser, Simone I., McCaughan, Geoffrey W., Carey, Sharon, Allman-Farinelli, Margaret, Shackel, Nicholas A.
發表在 Nutrients (2019)

Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study

由 Ruane, Peter, Strasser, Simone I., Gane, Edward J., Hyland, Robert H., Shao, Jiang, Dvory‐Sobol, Hadas, Tran, Tram, Stamm, Luisa M., Brainard, Diana M., Nyberg, Lisa, Shafran, Stephen
發表在 J Viral Hepat (2019)

The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation

由 Vidot, Helen, Kline, Katharine, Cheng, Robert, Finegan, Liam, Lin, Amelia, Kempler, Elise, Strasser, Simone I., Bowen, David Geoffrey, McCaughan, Geoffrey William, Carey, Sharon, Allman-Farinelli, Margaret, Shackel, Nicholas Adam
發表在 Nutrients (2019)

Reply to “Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.”...

由 Vidot, Helen, Kline, Katharine, Cheng, Robert, Finegan, Liam, Lin, Amelia, Kempler, Elise, Strasser, Simone I., Bowen, David Geoffrey, McCaughan, Geoffrey William, Carey, Sharon, Allman-Farinelli, Margaret, Shackel, Nicholas Adam
發表在 Nutrients (2020)

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

由 Lepida, Antonia, Colombo, Massimo, Fernandez, Inmaculada, Abdurakhmanov, Djamal, Abrao Ferreira, Paulo, Strasser, Simone I., Urbanek, Petr, Mangia, Alessandra, Calleja, José L., Iraqi, Wafae, DeMasi, Ralph, Lonjon-Domanec, Isabelle, Moreno, Christophe, Wedemeyer, Heiner
發表在 PLoS One (2015)

Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand

由 Chen, John WC, Kow, Lilian, Verran, Deborah J, McCall, John L, Munn, Stephen, Balderson, Glenda A, Fawcett, Jonathan W, Gow, Paul J, Jones, Robert M, Jeffrey, Gary P, House, Anthony K, Strasser, Simone I
出版 2009

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

由 Younossi, Zobair M., Stepanova, Maria, Noureddin, Mazen, Kowdley, Kris V., Strasser, Simone I., Kohli, Anita, Ruane, Peter, Shiffman, Mitchell L., Sheikh, Aasim, Gunn, Nadege, Caldwell, Stephen H., Huss, Ryan S., Myers, Robert P., Wai‐Sun Wong, Vincent, Alkhouri, Naim, Goodman, Zachary, Loomba, Rohit
發表在 Hepatol Commun (2021)

Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens

由 Reddy, K. Rajender, Pol, Stanislas, Thuluvath, Paul J., Kumada, Hiromitsu, Toyota, Joji, Chayama, Kazuaki, Levin, James, Lawitz, Eric J., Gadano, Adrian, Ghesquiere, Wayne, Gerken, Guido, Brunetto, Maurizia R., Peng, Cheng‐Yuan, Silva, Marcelo, Strasser, Simone I., Heo, Jeong, McPhee, Fiona, Liu, Zhaohui, Yang, Rong, Linaberry, Misti, Noviello, Stephanie
發表在 Liver Int (2017)

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

由 Foster, Graham R., Chayama, Kazuaki, Chuang, Wan-Long, Fainboim, Hugo, Farkkila, Martti, Gadano, Adrian, Gaeta, Giovanni B., Hézode, Christophe, Inada, Yukiko, Heo, Jeong, Kumada, Hiromitsu, Lu, Sheng-Nan, Marcellin, Patrick, Moreno, Christophe, Roberts, Stuart K., Strasser, Simone I., Thompson, Alexander J., Toyota, Joji, Paik, Seung Woon, Vierling, John M., Zignego, Anna L., Cohen, David, McPhee, Fiona, Wind-Rotolo, Megan, Srinivasan, Subasree, Hruska, Matthew, Myler, Heather, Portsmouth, Simon D.
發表在 Springerplus (2016)